![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 02, 2020 7:33:07 PM
Dr Mark Williams has worked in Eastern Europe and was / is planning Trials there for NASH/AGN, involving CKD and IBD things. Part of the initial reverse merger reason this is now AGN. Those Drugs have obviously taken a back seat right now but there are already connections over there, IMO.
Stuff pr'ed long ago when there was no COVID.
The currently recruiting Aussie / NZ Phase 2 Trials for IPF / CC were set up long ago too, through Novotech. These Trials seem to be relevant to COVID but are totally separate...JMO...GLTA...
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM